Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?
Authors:
- Opeyemi IwaloyeOIOpeyemi Iwaloye
- Paul Olamide OttuPOPaul Olamide Ottu
- Femi OlawaleFOFemi Olawale
- Olorunfemi Oyewole BabalolaOBOlorunfemi Oyewole Babalola
- Olusola Olalekan ElekofehintiOEOlusola Olalekan Elekofehinti
- Babatomiwa KikiowoBKBabatomiwa Kikiowo
- Abayomi Emmanuel AdegboyegaAAAbayomi Emmanuel Adegboyega
- Henry Nnaemeka OgbonnaHOHenry Nnaemeka Ogbonna
- Covenant Femi AdeboboyeCACovenant Femi Adeboboye
- Ibukun Mary FolorunsoIFIbukun Mary Folorunso
- Aderonke Elizabeth FakayodeAFAderonke Elizabeth Fakayode
- Moses Orimoloye AkinjiyanMAMoses Orimoloye Akinjiyan
Open Access
- 18 August 2023
- journal article
- review article
- Published by Elsevier in Informatics in Medicine Unlocked
- Vol. 41
Abstract
No abstract availableThis publication has 165 references indexed in Scilit:
- 3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell modelsBMC Pharmacology and Toxicology, 2013
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 MutationsNew England Journal of Medicine, 2012
- Pharmacophore and QSAR Studies to Design Novel Histone Deacetylase 2 InhibitorsChemical Biology & Drug Design, 2012
- From the protein's perspective: the benefits and challenges of protein structure-based pharmacophore modelingMedChemComm, 2011
- Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)Journal of Medicinal Chemistry, 2011
- Investigations on Inhibitors of Hedgehog Signal Pathway: A Quantitative Structure-Activity Relationship StudyInternational Journal of Molecular Sciences, 2011
- Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene MutationCase Reports in Oncology, 2010
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- An Unbiased Cell Morphology–Based Screen for New, Biologically Active Small MoleculesPLOS Biology, 2005
- Improved protein–ligand docking using GOLDProteins: Structure, Function, and Bioinformatics, 2003